NEUROONE MEDICAL TECHNOLOGIES CORPORATION - COMMON

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

12 Feb 2025 07:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

05 Feb 2025 10:00:00 By Nasdaq GlobeNewswire

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

04 Feb 2025 09:56:00 By Nasdaq GlobeNewswire

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

10 Jan 2025 07:30:00 By Nasdaq GlobeNewswire

NeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024

06 Jan 2025 07:30:00 By Nasdaq GlobeNewswire

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

03 Jan 2025 07:30:00 By Nasdaq GlobeNewswire

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

17 Dec 2024 07:30:00 By Nasdaq GlobeNewswire

NeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time

04 Dec 2024 07:30:00 By Nasdaq GlobeNewswire

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

31 Oct 2024 15:01:00 By Nasdaq GlobeNewswire

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

24 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

24 Sep 2024 08:30:00 By Nasdaq GlobeNewswire

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

10 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

05 Sep 2024 17:23:00 By Nasdaq GlobeNewswire

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

14 Aug 2024 15:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

12 Aug 2024 10:30:00 By Nasdaq GlobeNewswire

NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility

05 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System

25 Jun 2024 08:00:00 By Nasdaq GlobeNewswire

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

20 Jun 2024 08:30:00 By Nasdaq GlobeNewswire

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

14 May 2024 15:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

10 May 2024 13:43:56 By Nasdaq GlobeNewswire